Concepedia

Adi Rogel

AR

5

Publications

361

Citations

5

H-Index

2021

Active since

Affiliations

Weizmann Institute of Science(Current)

Tel Aviv University

Adi Rogel is an author at Weizmann Institute of Science specializing in medicine, pharmacology, and tumor biology.

Top concepts

MedicinePharmacologyOncologyChemistryBiochemistryCell BiologyTumor BiologyCancer BiologyCancer TherapyDrug Discovery

Publications per year

2021–2023

5

Publications

5

Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

Christian Dubiella, Benika J. Pinch, Kazuhiro Koikawa et al. · Nature Chemical Biology · 2021 · 141 citations · Full text

Covalent Inhibitor, Oncology, Malignant Disease +9

Tunable Methacrylamides for Covalent Ligand Directed Release Chemistry

Rambabu Reddi, Efrat Resnick, Adi Rogel et al. · Journal of the American Chemical Society · 2021 · 92 citations · Full text

Site-Specific Labeling of Endogenous Proteins Using CoLDR Chemistry

Rambabu Reddi, Adi Rogel, Efrat Resnick et al. · Journal of the American Chemical Society · 2021 · 78 citations · Full text

Sulfamate Acetamides as Self-Immolative Electrophiles for Covalent Ligand-Directed Release Chemistry

Rambabu Reddi, Adi Rogel, Ronen Gabizon et al. · Journal of the American Chemical Society · 2023 · 35 citations · Full text

Covalent Inhibitors, Drug Target, Organometallic Electrochemistry +18

Intracellular Protein–Drug Interactions Probed by Direct Mass Spectrometry of Cell Lysates

Rivkah Rogawski, Adi Rogel, Itai Bloch et al. · Angewandte Chemie International Edition · 2021 · 15 citations · Full text

Rows per page

1–5 of 5